- €16.65m
- €38.86m
- €43.13m
- 36
- 73
- 46
- 49
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.15 | ||
| PEG Ratio (f) | 0.16 | ||
| EPS Growth (f) | 100% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.51 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 3.03 | ||
| Price to Sales | 0.41 | ||
| EV to EBITDA | 10.15 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.98% | ||
| Return on Equity | -2.2% | ||
| Operating Margin | 1.27% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 19.98 | 32.17 | 33.46 | 51.29 | 43.13 | 39.6 | 41 | 28.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -26.26 | +262.3 | -72.75 | +38.47 | +100 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bio-Uv Group SAS is a France-based company, which operates as a manufacturer of ultraviolet light water treatment equipment. The Company designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to a number of applications, which enable automatic chlorine-free treatment for residential and collective swimming pools and spas. Bio-Uv Group SAS divides its range of products into two main segments: Individual, which includes residential pools & spas, fish ponds and aquariums and domestic drinking water for human consumption, and Professionals, which includes commercial pools and spas for professionals, water treatment, ballast water treatment, aquaculture, aquariums and fountains, among others.
Directors
- Benoit Gillmann CHM (64)
- Laurent-Emmanuel Migeon DCE (51)
- Simon Marshall DGD
- Anne Julia DSL
- Laurent Marques DSL
- Xavier Bayle OTH (56)
- Benoit Caribent OTH
- Xavier Deval OTH
- Patrick Lurati OTH
- Thierry Carles DRC
- Sylvie Roussel IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- October 13th, 2010
- Public Since
- July 10th, 2018
- No. of Employees
- 155
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
Euronext - Paris- Shares in Issue
- 10,213,057.52
- Address
- 850 avenue Louis Medard, LUNEL, 34403
- Web
- https://www.bio-uv.com/
- Phone
- +33 499133911
- Auditors
- PricewaterhouseCoopers Audit
Upcoming Events for ALTUV
Half Year 2025 Bio-UV Group SA Earnings Release
Similar to ALTUV
Adeunis SA
Euronext - Paris
Groupe Airwell SA
Euronext - Paris
Alstom SA
Euronext - Paris
Boostheat SAS
Euronext - Paris
Cerinnov SA
Euronext - Paris
FAQ
What is the Bio-UV SA share price?
As of Today at 19:36 UTC, shares in Bio-UV SA are trading at €1.63. This share price information is delayed by 15 minutes.
How has the Bio-UV SA share price performed this year?
Shares in Bio-UV SA last closed at €1.63 and the price had moved by -31.43% over the past 365 days. In terms of relative price strength the Bio-UV SA share price has underperformed the FTSE Global All Cap Index by -33.15% over the past year.
What are the analyst and broker recommendations for Bio-UV SA?
The overall consensus recommendation for Bio-UV SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Bio-UV SA dividend yield?
Bio-UV SA does not currently pay a dividend.
Does Bio-UV SA pay a dividend?
Bio-UV SA does not currently pay a dividend.
When does Bio-UV SA next pay dividends?
Bio-UV SA does not currently pay a dividend.
How do I buy Bio-UV SA shares?
To buy shares in Bio-UV SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bio-UV SA?
As of the previous close price of €1.63, shares in Bio-UV SA had a market capitalisation of €16.65m.
Where are Bio-UV SA shares listed?
Here are the trading details for Bio-UV SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALTUV
What kind of share is Bio-UV SA?
Based on an overall assessment of its quality, value and momentum Bio-UV SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bio-UV SA share price forecast for 2025?
The analyst consensus target price for shares in Bio-UV SA is €3.00. That is 84.05% above the last closing price of €1.63.
Analysts covering Bio-UV SA currently have a consensus Earnings Per Share (EPS) forecast of €0.10 for the next financial year.
Find out moreWhat is the trend in the Bio-UV SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bio-UV SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -15.82%.
As of the last closing price of €1.63, shares in Bio-UV SA were trading -16.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bio-UV SA PE Ratio?
The Bio-UV SA PE ratio based on its reported earnings over the past 12 months is 8.15. The shares last closed at €1.63.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bio-UV SA?
Bio-UV SA's management team is headed by:
- Benoit Gillmann - CHM
- Laurent-Emmanuel Migeon - DCE
- Simon Marshall - DGD
- Anne Julia - DSL
- Laurent Marques - DSL
- Xavier Bayle - OTH
- Benoit Caribent - OTH
- Xavier Deval - OTH
- Patrick Lurati - OTH
- Thierry Carles - DRC
- Sylvie Roussel - IND